FDA is emphasizing its interest in putting electronic cigarettes to work as OTC drugs by publishing a draft guidance on information needed from studies with animals for new drug applications for smoking cessation or similar indications.
In the draft guidance published Aug. 3, FDA states it provides "recommendations on the nonclinical information necessary to support development and approval of orally inhaled nicotine-containing drug products, including...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?